Eastern European countries continue to look beyond the Western firms supplying vaccines as the pandemic rages in this part of the world. Most recently, CanSino…
This week, the China National Medical Products Administration (NMPA) granted conditional marketing authorization of Recombinant COVID-19 Vaccine (Adenovirus Type 5 Vector) (the “Ad5-nCoV”, trade name:…
CanSino Biologics, one of China’s leading vaccine makers, inked a deal with Pakistan’s government to sell the Ad5-nCoV vaccine candidate to that nation selling 10,600,000…
Mexico was active recently in the investigational vaccine market, securing two deals with two different companies for a total of 151 million doses of experimental…
Pakistan, the fifth most populous nation in the world, recently geared up to support a Phase 3 COVID-19 vaccine clinical trial sponsored by a Chinese…
Please confirm you want to block this member.
You will no longer be able to:
Please note: This action will also remove this member from your connections and send a report to the site admin. Please allow a few minutes for this process to complete.
